Employee drug testing for cannabinoids: What you should know

    September 01, 2022 2 min read

    Employee drug testing for cannabinoids: What you should know

    Mandatory drug testing is common in the workplace. A tempting workaround for consumers of therapeutic cannabinoids, such as CBD, is to reach for ‘synthetics’, thinking they do not contain THC, the psychoactive component of cannabis or cannabis-derived products. 

    The truth is that synthetic CBD, if its extraction source was the cannabis plant, does contain trace amounts of THC. Removing it completely from the end-product is enormously difficult, and also time-consuming and costly. 

    This unintentional residue, even in small amounts, can cause problems in drug testing. The solution is to use CBD that derives from a source that isn’t marijuana. 

    We don’t use marijuana at PureForm. That’s why our wellness and pharmaceutical products are free of cannabis-related regulatory scrutiny. We transform aromatic terpene oils from other plant sources into pure – really pure – CBD, entirely free of THC – and also free of any of the plant pesticides, microbial contaminants, or heavy metals that can also come with agricultural cannabis production. 

    This process is so good that PureForm has been awarded the Purity Award and the THC Free Award from the prestigious Clean Label Project, an industry watchdog dedicated to transparency and consumer safety. 

    Products whose active ingredient is PureForm CBD can be used with no risk at all of accidental detection of THC or any other unwanted molecule in drug testing. 



    PureForm CBD™ is bioidentical to CBD extracted from hemp and cannabis but without residual cannabinoids like THC or any of the impurities or chemicals associated with plant-derived production processes. Our molecular assembly technique, that synthesizes CBD from aromatic terpenes instead of cannabis, assures you the food and pharmaceutical-grade quality that you need for quality-conscious customers. If you are interested in PureForm CBD™ or want to partner on any other of the 140+ known cannabinoids, please contact Damian Peters at 310-666-4869, or email info@pureformglobal.com


    The foregoing is a report on trends and developments in the cannabinoid industry. No product described herein is intended to diagnose, treat, cure or prevent any disease or syndrome.